THR-β agonist 2 is a potent THR-β agonist with potential for the treatment of metabolic disorders such as obesity, hyperlipidemia, hypercholesterolemia, diabetes, as well as conditions including steatosis, non-alcoholic steatohepatitis (NASH), atherosclerosis, and other related diseases.